Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0RAD stock hub

LON/0RAD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RADis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

74.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RAD

In the news

Latest news · LON/0RAD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-66.8

P25 n/aP50 n/aP75 n/a

ROIC-66.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RAD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

EUR

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	64
Employees Change	9%
Employees Change Percent	16.36
Enterprise value	EUR 81.7M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	FR0012127173
Last refreshed	2026-05-10
Market cap	EUR 74.9M
Price	EUR 3.88
Price currency	EUR
Rev Per Employee	24,290.14x
Sic	2836
Symbol	lon/0RAD
Website	https://www.ose-immuno.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-37.89%
EV Earnings	-2.88x
EV/FCF	-3.46x
EV/Sales	53.05x
FCF yield	-31.52%
P/B ratio	2.56x
P/S ratio	48.16x
PE Ratio3 Y	5.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 1.6M
Gross Profit Growth	-97.86%
Gross Profit Growth Q	-0.81%
Gross Profit Growth3 Y	-15.18%
Gross Profit Growth5 Y	-41.42%
Net Income	EUR -28.4M
Pretax Margin	-1,824.86%
Profit Per Employee	EUR -443,261
ROA	-18.42
Roa5y	-6.16
ROCE	-50.4
ROE	-66.82
Roe5y	-27.63
ROIC	-66.55
Roic5y	-19.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-39.31%
Cagr3y	2.25%
Cagr5y	-18.72%
Revenue Growth	-95.84x
Revenue Growth Q	-0.81x
Revenue Growth3 Y	-15.18x
Revenue Growth5 Y	-41.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.02
Assets	EUR 73.5M
Cash	EUR 24.3M
Current Assets	EUR 60.5M
Current Liabilities	EUR 17.5M
Debt	EUR 31.1M
Debt Equity	EUR 1.06
Debt FCF	EUR -1.32
Equity	EUR 29.2M
Liabilities	EUR 44.2M
Long Term Assets	EUR 13M
Long Term Liabilities	EUR 26.7M
Net Cash	EUR -6.8M
Net Cash By Market Cap	EUR -9.15
Net Debt Equity	EUR 0.23
Tangible Book Value	EUR -8.4M
Tangible Book Value Per Share	EUR -0.38
WACC	5.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.54
Net Working Capital	EUR -2.9M
Quick ratio	1.19
Working Capital	EUR 10.9M
Working Capital Turnover	EUR 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-39.29%
200-day SMA	5.16
3Y total return	6.89%
50-day SMA	3.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.52%
All Time High	13.65
All Time High Change	-71.36%
All Time High Date	2021-03-03
All Time Low	2.73
All Time Low Change	43.07%
All Time Low Date	2023-08-29
ATR	0.26
Beta	0.68
Ch YTD	-26.09
High	3.97
High52	7.64
High52 Date	2025-10-02
High52ch	-49.27%
Low	3.88
Low52	2.95
Low52 Date	2026-03-27
Low52ch	31.3%
Ma50ch	5.36%
Price vs 200-day SMA	-24.18%
RSI	55.78
RSI Monthly	40.72
RSI Weekly	42.55
Sharpe ratio	-0.53x
Sortino ratio	-0.73
Total Return	-3.76%
Tr YTD	-26.09
Tr1m	15%
Tr1w	5.96%
Tr3m	-8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -26.8M
Operating margin	-1,721.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,205,887%
Net Borrowing	-6,227,363.1
Shares Insiders	24.14%
Shares Institutions	3.18%
Shares Qo Q	3.65%
Shares Yo Y	3.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -23.6M
Average Volume	5,689.5x
Bv Per Share	1.33
CAPEX	EUR -392,568
Ch1m	15
Ch1w	5.96
Ch1y	-39.29
Ch3m	-8
Ch3y	6.89
Ch5y	-64.52
Ch6m	-25.17
Change	-0.87%
Change From Open	-0.1
Close	3.91
Days Gap	-0.77
Depreciation Amortization	1,044,958.3
Dollar Volume	713.2
Earnings Date	2026-04-29
EBIT	EUR -26.8M
EBITDA	EUR -25.7M
EPS	EUR -1.29
F Score	2
FCF	EUR -23.6M
FCF EV Yield	-28.9x
Financing CF	-6,799,274
Fiscal Year End	December
Founded	2,012
Investing CF	31,112,307
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2024-12-31
Ma150	4.99
Ma150ch	-21.69%
Ma20	3.5
Ma20ch	11.65%
Net CF	1,107,041
Next Earnings Date	2026-09-28
Open	3.88
Position In Range	0
Ppne	2,962,733.5
Price Date	2026-05-08
Relative Volume	0.03x
Revenue	1,554,569x
Tr6m	-25.17%
Volume	184

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RAD pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RAD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RAD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.2%

Share of float held by funds and institutions

Insider ownership

+24.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.8%

Negative means the company is buying back shares.

Technical

LON/0RAD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.8

Neutral momentum band

Price vs 200-day MA

-24.2%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RAD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RAD stock rating?

lon/0RAD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RAD analysis?

The full report lives at /stocks/lon/0RAD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RAD?

The latest report frames lon/0RAD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RAD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.